6.26
price down icon2.72%   -0.17
after-market Handel nachbörslich: 6.26
loading

Recursion Pharmaceuticals Inc Aktie (RXRX) Neueste Nachrichten

pulisher
11:01 AM

RXRX September 5th Options Begin Trading - Nasdaq

11:01 AM
pulisher
Jul 23, 2025

Recursion Pharmaceuticals Experiences 10.7% Stock Price Surge Amid Strong Investor Interest - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Recursion Pharmaceuticals (RXRX) Jumps 9.6% Ahead of Q2 Earnings - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Can Recent Pipeline Expansion Efforts Offset RXRX's Earlier Losses? - The Globe and Mail

Jul 23, 2025
pulisher
Jul 23, 2025

3 AI Stocks Partnered With Nvidia With Massive Growth Opportunities - The Motley Fool

Jul 23, 2025
pulisher
Jul 22, 2025

Is Recursion Pharmaceuticals Inc. a good long term investmentFree Investment Case Studies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Recursion Pharmaceuticals Inc. stock priceRapid growth trajectories - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Recursion Pharmaceuticals Trading Volume Drops 52.75% to $23.7 Million, Ranks 464th in Market - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

Recursion Pharmaceuticals Inc. Stock Analysis and ForecastHigh-velocity capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Recursion Pharmaceuticals Sees Sharp Gain on AI Biotech Optimism - FinancialContent

Jul 22, 2025
pulisher
Jul 22, 2025

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Yahoo.co

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Recursion Pharmaceuticals Inc. stockOver 200% growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Top 2 Health Care Stocks You May Want To Dump This Quarter - Benzinga

Jul 22, 2025
pulisher
Jul 22, 2025

(RXRX) Trading Signals - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

Here's Why Shares in Recursion Pharmaceuticals Surged Today - AOL.com

Jul 22, 2025
pulisher
Jul 21, 2025

Recursion Pharmaceuticals Surges 58.77% in Trading Volume Reaching 207th Position in Market Rankings - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

History of Recursion Pharmaceuticals, Inc.: AI‑Driven Drug Discovery Beginnings (NASDAQ:RXRX) - FinancialContent

Jul 21, 2025
pulisher
Jul 21, 2025

RXRX Surges Ahead: Is It Time to Jump In? - timothysykes.com

Jul 21, 2025
pulisher
Jul 21, 2025

Recursion Pharmaceuticals Options Trading: A Deep Dive into Market Sentiment - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Recursion Pharmaceuticals Stock (RXRX) Opinions on Recent Price Surge - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Recursion Pharmaceuticals’ Stock Soars as It Gains Full Rights to REV102 - StocksToTrade

Jul 21, 2025
pulisher
Jul 21, 2025

Recursion Pharmaceuticals Surges 5.8%: Will Momentum Continue? - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Why Is Recursion Pharma Stock Surging On Monday? - Benzinga

Jul 21, 2025
pulisher
Jul 21, 2025

Recursion Pharmaceuticals (RXRX) Stock Jumps After Acquiring Full Rights to REV102 for Rare Bone Disorder - FinancialBuzz.com

Jul 21, 2025
pulisher
Jul 21, 2025

Recursion Pharmaceuticals Stock Soars Amid Investor Optimism - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock? - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

Layoff Tracker: GSK, Sail, BioNTech Cut Staff for Second Time This Year - BioSpace

Jul 21, 2025
pulisher
Jul 20, 2025

Recursion Bets On AI Drug Discovery Despite Volatile Year - Finimize

Jul 20, 2025
pulisher
Jul 19, 2025

Recursion Pharmaceuticals (RXRX) Sees 14% Price Surge Over Last Month - Yahoo Finance

Jul 19, 2025
pulisher
Jul 19, 2025

Recursion Pharmaceuticals Experiences Elevated Call Volume and Implied Volatility. - AInvest

Jul 19, 2025
pulisher
Jul 19, 2025

Recursion Pharmaceuticals (RXRX) Is Up 10.6% After Expanding AI Partnerships and Acquiring Exscientia - simplywall.st

Jul 19, 2025
pulisher
Jul 19, 2025

Recursion to buy Rallybio’s ownership in jointly developed bone disorder drug - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

Recursion Pharmaceuticals Surges to 360th in Market Rankings with $312 Million Trading Volume - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Recursion Pharmaceutical’s Latest Acquisition: A Game Changer? - timothysykes.com

Jul 18, 2025
pulisher
Jul 18, 2025

Why Did Recursion Soar 12%? - timothysykes.com

Jul 18, 2025
pulisher
Jul 18, 2025

10 Best Small Cap AI Stocks to Buy According to Analysts - Insider Monkey

Jul 18, 2025
pulisher
Jul 18, 2025

Recursion Pharmaceuticals Soars After Strategic Acquisition - StocksToTrade

Jul 18, 2025
pulisher
Jul 18, 2025

Why Recursion Pharmaceuticals Stock is Climbing - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Recursion Pharmaceuticals Acquires Full Rights to REV102, Bolstering Stock Performance - timothysykes.com

Jul 18, 2025
pulisher
Jul 17, 2025

Can RXRX's AI-Based Approach Revolutionize the Drug Discovery Process? - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

Recursion Pharmaceuticals (RXRX) Rises Higher Than Market: Key Facts - MSN

Jul 17, 2025
$23.63
price up icon 3.30%
$36.59
price up icon 1.58%
$103.52
price up icon 0.10%
$27.57
price down icon 1.54%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.65%
Kapitalisierung:     |  Volumen (24h):